Determinants of physical activity level in pediatric oncological patients treated with cardiotoxic therapy – a study protocol
Abstract Background Childhood cancer and its therapy, especially that involving potentially cardiotoxic cancer treatment, can structurally affect muscle strength and heart function, and therefore may result in lowered physical activity (PA). This study protocol aims to find the significant determina...
Saved in:
| Main Authors: | Julia Haponiuk-Skwarlińska, Jakub S. Gąsior, Katarzyna Albrecht, Paweł Łaguna, Bożena Werner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Pediatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12887-025-05714-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined Utility of Speckle Tracking Echocardiography and Cardiac Biomarkers for Early Detection of Anthracycline-Induced Cardiotoxicity in Pediatric Oncology Patients
by: Cristiana Stolojanu, et al.
Published: (2024-12-01) -
Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01) -
Lifestyle and Pharmacological Interventions to Prevent Anthracycline-Related Cardiotoxicity in Cancer Patients
by: Luigi Spadafora, et al.
Published: (2025-06-01) -
Evaluation of pediatric patients with an oncologic emergency: Single center experience
by: Ahmet Çağrı Çiftçi, et al.
Published: (2018-12-01) -
Cardiotoxicity of genetic engineered biological therapy in immuno-mediated and oncological diseases
by: V. A. Akhmedov, et al.
Published: (2024-04-01)